SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
Clinical trial NCT02580305 · COMPLETED
Trial details
- NCT number
- NCT02580305
- Sponsor
- Suven Life Sciences Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2019-11-05
- Enrollment
- 564
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.